RESEARCH PAPER

Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s

S M Carter, S Chapman^*

School of Public Health, University of Sydney, Sydney, Australia

Correspondence to:
Correspondence to:
Stacy M Carter
School of Public Health, Room 128A Building A27, University of Sydney NSW 2006, Australia; carters{at}health.usyd.edu.au

Objective: To contrast the Australian tobacco industry’s awareness of the diseases caused by smoking with their aggressive public denial on the relation between smoking and disease in the 1980s.

Design: Analysis of 325 industry documents from the world wide web.

Results: In the 1980s Australian cigarette manufacturers were informed constantly by the international industry of the medical consensus that smoking caused disease. In addition Philip Morris (Australia) Limited received reports of Philip Morris’ international biological research programme and visited its Richmond research facility; and WD&HO Wills part funded, co-managed, and contributed research to the British American Tobacco groups’ biological research programme. Despite this knowledge, the Australian manufacturers had a policy of arguing to their employees, decision makers, and the general public that questions of smoking and disease were unresolved. The industry catalogued the literature, developed arguments against the main claims made by health groups, and attacked public health advocates who made statements linking smoking to death and disease. Industry studies suggested that a 20–30% minority of the Australian public agreed with the industry on smoking and disease, diminishing across the decade.

Conclusion: Australian manufacturers were clearly negligent in the 1980s, deliberately working to undermine Australians’ understandings of the diseases caused by smoking despite their own private knowledge. Continuing scepticism about smoking and disease, corresponding with the industry’s deceptions, exists in Australian smokers today, suggesting that their actions may have slowed the rate of decline in smoking prevalence. These revelations provide important evidence for Australian litigation and advocacy.

Keywords: Australia; consumer product safety; research; smoking related disease; tobacco industry

Abbreviations: ACCI, Australian Chamber of Commerce and Industry; BAT, British American Tobacco; CAC, Chairman’s Advisory Conference (BAT); CORESTA, Cooperation Centre for Scientific Research Relative to Tobacco; GR&DC, Group Research and Development Centre; PMI, Philip Morris International; PML, Philip Morris (Australia) Limited; SRG, scientific research group; TIA, Tobacco Institute of Australia

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Liberman, J. (2006). The future of tobacco regulation: a response to a proposal for fundamental institutional change.. Tobacco Control 15: 333-338 [Abstract] [Full Text]  
• Durkin, S J, Germain, D, Wakefield, M (2005). Adult's perceptions about whether tobacco companies tell the truth in relation to issues about smoking. Tobacco Control 14: 429-430 [Full Text]  
• Chapman, S, Liberman, J (2005). Ensuring smokers are adequately informed: reflections on consumer rights, manufacturer responsibilities, and policy implications. Tobacco Control 14: ii8-ii13 [Abstract] [Full Text]  
• Alechnowicz, K, Chapman, S (2004). The Philippine tobacco industry: "the strongest tobacco lobby in Asia". Tobacco Control 13: ii71-ii78 [Abstract] [Full Text]  
• Chapman, S, Byrne, F, Carter, S M (2003). "Australia is one of the darkest markets in the world": the global importance of Australian tobacco control. Tobacco Control 12: iii1-3 [Abstract] [Full Text]